RT Book, Section A1 Chesnutt, Asha N. A1 Chesnutt, Mark S. A1 Prendergast, Niall T. A1 Prendergast, Thomas J. A2 Papadakis, Maxine A. A2 McPhee, Stephen J. A2 Rabow, Michael W. SR Print(0) ID 1175807983 T1 Alveolar Hemorrhage Syndromes T2 Current Medical Diagnosis & Treatment 2021 YR 2021 FD 2021 PB McGraw-Hill Education PP New York, NY SN 9781260469868 LK accessmedicine.mhmedical.com/content.aspx?aid=1175807983 RD 2023/02/05 AB Diffuse alveolar hemorrhage may occur in a variety of immune and nonimmune disorders. Alveolar infiltrates on chest radiograph, dyspnea, anemia, hemoptysis, and occasionally fever are characteristic. Rapid clearing of diffuse lung infiltrates within 2 days is a clue to the diagnosis of diffuse alveolar hemorrhage (eFigure 9–26). Pulmonary hemorrhage can be associated with an increased single-breath diffusing capacity for carbon monoxide (DLCO).